Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-09 4:07 pm Sale |
2025-06-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Rubric Capital Management LP | 6,256,847 4.120% |
-8,143,153 (-56.55%) |
Filing History |
| 2025-06-06 1:40 pm Sale |
2025-05-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 4,398,669 2.900% |
-3,333,901 (-43.12%) |
Filing History |
| 2025-05-14 10:34 am Purchase |
2025-03-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 7,732,570 5.200% |
1,664,761 (+27.44%) |
Filing History |
| 2025-05-07 11:42 am Sale |
2025-04-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 6,067,809 3.990% |
-3,356,265 (-35.61%) |
Filing History |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
BlackRock Inc. BLK |
9,940,846 6.700% |
-1,480,708 (-12.96%) |
Filing History |
| 2025-02-14 11:23 am Sale |
2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 9,424,074 6.390% |
-3,382,439 (-26.41%) |
Filing History |
| 2025-02-13 2:20 pm Sale |
2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
Nikko Asset Management Americas Inc. | 6,833,137 4.630% |
-900,747 (-11.65%) |
Filing History |
| 2025-02-04 06:13 am Sale |
2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
Sumitomo Mitsui Trust Group, Inc. | 6,833,137 4.600% |
-900,747 (-11.65%) |
Filing History |
| 2025-01-27 4:00 pm Sale |
2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
Integrated Core Strategies (US) LLC | 6,292,634 4.300% |
-3,107,939 (-33.06%) |
Filing History |
| 2024-11-13 4:30 pm Purchase |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Rubric Capital Management LP | 14,400,000 9.760% |
14,400,000 (New Position) |
Filing History |
| 2024-11-13 09:00 am Sale |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Matrix Capital Management Company LP | 650,000 0.440% |
-10,922,590 (-94.38%) |
Filing History |
| 2024-11-12 1:30 pm Unchanged |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 10,639,440 7.210% |
0 (Unchanged) |
Filing History |
| 2024-11-08 3:15 pm Purchase |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Nikko Asset Management Americas Inc. | 7,733,884 5.240% |
7,733,884 (New Position) |
Filing History |
| 2024-11-05 06:07 am Purchase |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Sumitomo Mitsui Trust Group, Inc. | 7,733,884 5.240% |
7,733,884 (New Position) |
Filing History |
| 2024-11-04 10:58 am Sale |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 10,639,440 7.210% |
-2,128,244 (-16.67%) |
Filing History |
| 2024-10-11 4:14 pm Purchase |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Integrated Core Strategies (US) LLC | 9,400,573 6.400% |
1,650,440 (+21.30%) |
Filing History |
| 2024-05-28 4:22 pm Purchase |
2024-05-17 | 13G | Adaptive Biotechnologies Corporation ADPT |
Integrated Core Strategies (US) LLC | 7,750,133 5.300% |
7,750,133 (New Position) |
Filing History |
| 2024-02-14 10:23 am Unchanged |
2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
VIKING GLOBAL INVESTORS LP | 29,993,708 20.700% |
0 (Unchanged) |
Filing History |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 12,767,684 8.820% |
973,516 (+8.25%) |
Filing History |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
ARK Investment Management LLC | 12,806,513 8.850% |
3,605,268 (+39.18%) |
Filing History |